PFM Health Sciences’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-186,635
| Closed | -$48M | – | 66 |
|
|
2023
Q3 | $48M | Sell |
186,635
-11,699
| -6% | -$3.01M | 2.26% | 14 |
|
|
2023
Q2 | $56.5M | Buy |
+198,334
| New | +$56.5M | 2.19% | 12 |
|
|
2023
Q1 | – | Sell |
-155,659
| Closed | -$43.1M | – | 78 |
|
|
2022
Q4 | $43.1M | Buy |
155,659
+16,333
| +12% | +$4.52M | 1.54% | 21 |
|
|
2022
Q3 | $37.2M | Buy |
+139,326
| New | +$37.2M | 1.35% | 31 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 76 |
|
|
2021
Q4 | – | Sell |
-16,900
| Closed | -$4.78M | – | 72 |
|
|
2021
Q3 | $4.78M | Sell |
16,900
-115,372
| -87% | -$32.7M | 0.14% | 67 |
|
|
2021
Q2 | $45.8M | Buy |
132,272
+30,238
| +30% | +$10.5M | 1.44% | 28 |
|
|
2021
Q1 | $28.5M | Sell |
102,034
-12,570
| -11% | -$3.52M | 0.87% | 43 |
|
|
2020
Q4 | $28.1M | Buy |
114,604
+24,888
| +28% | +$6.09M | 0.99% | 33 |
|
|
2020
Q3 | $25.5M | Buy |
+89,716
| New | +$25.5M | 1.18% | 30 |
|
|
2020
Q2 | – | Sell |
-81,013
| Closed | -$25.6M | – | 68 |
|
|
2020
Q1 | $25.6M | Sell |
81,013
-147,315
| -65% | -$46.6M | 2.11% | 20 |
|
|
2019
Q4 | $67.8M | Buy |
+228,328
| New | +$67.8M | 3.23% | 6 |
|
|
2017
Q3 | – | Sell |
-4,046
| Closed | -$1.1M | – | 82 |
|
|
2017
Q2 | $1.1M | Sell |
4,046
-386,618
| -99% | -$105M | 0.03% | 84 |
|
|
2017
Q1 | $107M | Sell |
390,664
-195,046
| -33% | -$53.3M | 2.67% | 4 |
|
|
2016
Q4 | $166M | Sell |
585,710
-5,141
| -0.9% | -$1.46M | 4.68% | 1 |
|
|
2016
Q3 | $185M | Buy |
590,851
+255,561
| +76% | +$80M | 5.41% | 1 |
|
|
2016
Q2 | $81.1M | Buy |
+335,290
| New | +$81.1M | 2.45% | 7 |
|
|
2013
Q3 | – | Sell |
-96,017
| Closed | -$20.7M | – | 72 |
|
|
2013
Q2 | $20.7M | Buy |
+96,017
| New | +$20.7M | 0.43% | 49 |
|